Biomind Labs Inc.
BMNDF
$0.0158
-$0.0842-84.20%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 300.00 | 100.00 | 100.00 | 10.10K | 33.20K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 21.00K | 21.00K | 21.00K | 21.00K | -- |
Total Current Assets | 21.20K | 21.10K | 21.10K | 31.10K | 33.20K |
|
|||||
Total Current Assets | 21.20K | 21.10K | 21.10K | 31.10K | 33.20K |
Net Property, Plant & Equipment | 0.00 | -- | 20.10K | 22.30K | 24.50K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 21.20K | 21.10K | 41.20K | 53.40K | 57.80K |
|
|||||
Total Accounts Payable | 559.90K | 320.70K | 447.10K | 327.00K | 473.30K |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 648.10K | 628.50K | 670.70K | 883.20K | 1.03M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 312.00K | 434.30K | 223.60K | 365.40K | 404.20K |
Total Other Current Liabilities | 312.00K | 434.30K | 223.60K | 365.40K | 404.20K |
Total Current Liabilities | 1.52M | 1.38M | 1.34M | 1.58M | 1.91M |
|
|||||
Total Current Liabilities | 1.52M | 1.38M | 1.34M | 1.58M | 1.91M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 648.10K | 628.50K | 670.70K | 883.20K | 1.03M |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.52M | 1.38M | 1.34M | 1.58M | 1.91M |
|
|||||
Common Stock & APIC | 11.45M | 11.45M | 11.45M | 11.43M | 11.10M |
Retained Earnings | -15.07M | -14.95M | -14.88M | -15.06M | -15.02M |
Treasury Stock & Other | 2.12M | 2.14M | 2.14M | 2.11M | 2.07M |
Total Common Equity | -1.50M | -1.36M | -1.30M | -1.52M | -1.85M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -1.50M | -1.36M | -1.30M | -1.52M | -1.85M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -1.50M | -1.36M | -1.30M | -1.52M | -1.85M |
|